Congenital adrenal hyperplasia.
A clinical spectrum, varying from prenatal onset to postnatal onset of symptoms, exists in all hyperandrogenic forms of congenital adrenal hyperplasia (CAH). Postnatal onset hyperandrogenic symptoms such as premature pubarche, clitoromegaly, hirsutism, menstrual disorders and infertility are well known manifestations of CAH due to 21-hydroxylase deficiency, 3 beta-hydroxysteroid dehydrogenase deficiency or 11 beta-hydroxylase deficiency. These hyperandrogenic symptoms of CAH are clinically indistinguishable from other causes of hyperandrogenism. The molecular data has proven the genetic basis for the phenotypic variability of CAH disorders. Specific hormonal criterion(a) defined by the molecular proof of the disorder should aid in discriminating between symptomatic patients due to CAH and other causes, and between those with mild and severe CAH disorders. Prevalence of the hyperandrogenic forms of CAH, as well as pubertal maturation and reproductive function in women with hyperandrogenic forms of CAH, are discussed.
Pang
S
S
Department of Pediatrics, University of Illinois at Chicago College of Medicine, University of Illinois Hospital 60612, USA.
D015096:3-Hydroxysteroid Dehydrogenases / Q000172:deficiency*; D000312:Adrenal Hyperplasia, Congenital / Q000150:complications* / Q000235:genetics / Q000628:therapy; D005260:Female; D005298:Fertility; D006579:Heterozygote; D006801:Humans; D010641:Phenotype; D011627:Puberty; D013255:Steroid 21-Hydroxylase / Q000235:genetics
D015096:3-Hydroxysteroid Dehydrogenases; D013255:Steroid 21-Hydroxylase